Related Experiment Video
Updated: Jul 14, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Severity of SARS-CoV-2 infection in a hospital population: a clinical comparison across age groups
Chiara Rosazza1, Laura Alagna2, Alessandra Bandera2,3
1Paediatric Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Insights
COVID-19 (coronavirus disease 2019) is generally less severe in children compared to adults. While rare, multisystem inflammatory syndrome in children (MIS-C) is a serious complication, and its risk factors remain unknown.
Area of Science:
- Infectious Diseases
- Pediatrics
- Epidemiology
Background:
- Children typically experience milder COVID-19 (coronavirus disease 2019) than adults.
- However, post-acute complications of SARS-CoV-2 infection have been noted in pediatric populations.
- This study investigates COVID-19 outcomes and long-term complications in children versus adults.
Purpose of the Study:
- To compare COVID-19-related outcomes and long-term complications between pediatric and adult patients.
- To assess the severity of SARS-CoV-2 infection across different age groups.
- To determine the relative risk of severe COVID-19 outcomes, including hospitalization and need for supplemental oxygen.
Main Methods:
- Prospective, multicentre study (DECO COVID-19) including 154 individuals with RT-PCR-confirmed SARS-CoV-2 infection.
- Comparison of COVID-19 severity across three age groups: children/adolescents (<18 years), young/middle-aged adults (18-64 years), and older adults.
- Log-binomial models were used to estimate the relative risk (RR) of severe COVID-19, defined by hospitalization and/or supplemental oxygen requirement.
Main Results:
- Children/adolescents (84) had a lower risk of hospitalization (RR: 0.49) and supplemental oxygen need (RR: 0.12) compared to young/middle-aged adults.
- Older adults showed a higher risk of hospitalization (RR: 1.52) and supplemental oxygen need (RR: 1.46).
- Three children developed multisystem inflammatory syndrome (MIS-C); none required intensive care or reported post-acute complications.
Conclusions:
- COVID-19 (coronavirus disease 2019) is confirmed to be less severe in the pediatric population.
- Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe complication of SARS-CoV-2 infection.
- Risk factors for MIS-C in children are currently unknown and require further investigation.
Background:
Children tend to have milder forms of COVID-19 than adults, however post-acute complications have been observed also in the paediatric population. In this study, we compared COVID-19-related outcomes and long-term complications between paediatric and adult patients infected by SARS-CoV-2.
Methods:
The study is based on individuals enrolled from October 2020 to June 2021 in the DECO COVID-19 multicentre prospective study supported by the Italian Ministry of Health (COVID-2020-12371781). We included individuals with RT-PCR -confirmed SARS-CoV-2 infection, who were evaluated in the emergency department and/or admitted to COVID-dedicated wards. The severity of SARS-CoV-2 infection was compared across age groups (children/adolescents aged < 18 years, young/middle-aged adults aged 18-64 years and older individuals) through the relative risk (RR) of severe COVID-19. Severity was defined by: 1) hospitalization due to COVID-19 and/or 2) need or supplemental oxygen therapy. RR and corresponding 95% confidence intervals were estimated using log-binomial models.
Results:
The study included 154 individuals, 84 (54.5%) children/adolescents, 50 (32.5%) young/middle-aged adults and 20 (13%) older adults. Compared to young/middle-aged adults the risk of hospitalization was lower among paediatric patients (RR: 0.49, 95% CI: 0.32-0.75) and higher among older adults (RR: 1.52, 95% CI: 1.12-2.06). The RR of supplemental oxygen was 0.12 (95% CI: 0.05-0.30) among children/adolescents and 1.46 (95% CI: 0.97-2.19) among older adults. Three children developed multisystem inflammatory syndrome (MIS-C), none was admitted to intensive care unit or reported post-acute Covid-19 complications.
Conclusions:
Our study confirms that COVID-19 is less severe in children. MIS-C is a rare yet severe complication of SARS-CoV-2 infection in children and its risk factors are presently unknown.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
10:25Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Stages of Infection
Pneumonia III: Complications and Assessment
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Hospitals-II
Nurses that work in...
Pneumonia II: Pathophysiology